About, Editorial Feature
Published by Global M&A Network, the first-ever “Guide” will spotlight top private equity, growth investors and deal advisory firms from the healthcare industries that have the most experienced team and an impressive record for closing value-creating transactions. There are countless firms in the industry, and only the best firms with the brightest teams will be qualified based on their differentiated attributes.
Who, Firm Criteria:
Investors: A clear focus of investing in the healthcare industry, including any of the sub-sectors – healthcare systems, physician groups, tech, services, and life sciences such as pharma, devices, etc.; (B) Deal type include buyouts, growth, distressed, or co-investments involving equity commitment; (C) Transactions completed in 2021 (deal size is irrelevant).
Deal Advisors: M&A investment banks, law, lenders, restructuring, transaction services firms with a dedicated healthcare team; (B) Served as primary advisor to deals closed during the 2021 timeframe (deal size is irrelevant).
How, Firm Submissions:
Eligibility standards per above, merits of submission, invite based on our research/due diligence. Firms with incomplete info or no-info per invite/response are either excluded or included with blank content for the published firm profile page. There are no submission fees.
Firm Submission Download Form: There are no submission fees. Deadline: March 5, 2022.
When, Announcement and Publishing:
The “Guide” is announced during the Healthcare: Growth & Deals Virtual Forum. Profiles of the firms is published online 15 days after the virtual forum. We appreciate your cooperation in submitting the materials as requested. Featured firms must obtain reprint / licensing rights for their marketing/PR. Firms also have the option per their choice to upgrade their on-line profiles.
